InvestorsHub Logo
Followers 2
Posts 1798
Boards Moderated 0
Alias Born 01/05/2017

Re: None

Wednesday, 12/13/2017 12:00:34 PM

Wednesday, December 13, 2017 12:00:34 PM

Post# of 108191
So many companies mentioned in the article and ADXS nowhere in sight :(

"Over the next decade, immunotherapies will be the backbone of cancer treatments in 60% of cancer types. It is forecast that by 2020, Avastin, Nivolumab, Revlimid, Rituxan and Xtandi will be the top five cancer drugs."

Source:
https://www.barchart.com/story/stocks/quotes/BGNE/5102163/global-80-billion-cancer-immunotherapy-market-to-2022
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News